BioCentury
ARTICLE | Clinical News

Avastin bevacizumab: Phase III started

January 26, 2009 8:00 AM UTC

Last quarter, Genentech began the open-label Phase III ECOG 1305 trial to evaluate cisplatin plus docetaxel or fluorouracil with or without IV Avastin in 400 patients. Genentech markets Avastin in the...